TECON BIOLOGY Co.LTD - Laporan Laba Rugi (TTM)

TECON BIOLOGY Co.LTD
CN ˙ SZSE ˙ CNE000001PZ9
CN¥ 6.64 ↑0.02 (0.30%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi TECON BIOLOGY Co.LTD menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 10,917 11,987 13,342 15,200 15,695 15,711 15,764 15,803 16,267 16,989 17,488 17,944 18,810 19,026 18,912 18,056 17,407 17,176 17,579
Change (%) 9.80 11.31 13.92 3.26 0.10 0.34 0.25 2.94 4.44 2.94 2.61 4.83 1.15 -0.60 -4.53 -3.59 -1.33 2.35
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 7,423 8,592 9,857 12,147 13,803 14,595 15,107 15,253 15,031 15,375 15,780 16,681 17,900 18,965 18,724 17,230 16,380 15,103 15,480
Change (%) 15.75 14.72 23.23 13.63 5.73 3.51 0.96 -1.45 2.28 2.64 5.71 7.31 5.95 -1.27 -7.98 -4.93 -7.80 2.50
% of Revenue 67.99 71.68 73.88 79.91 87.95 92.89 95.84 96.52 92.40 90.50 90.23 92.96 95.16 99.68 99.01 95.42 94.10 87.93 88.06
Gross Operating Profit 3,494 3,395 3,486 3,053 1,892 1,116 656 550 1,236 1,615 1,708 1,263 909 61 188 826 1,027 2,073 2,099
Change (%) -2.85 2.68 -12.41 -38.04 -40.99 -41.21 -16.22 124.76 30.63 5.79 -26.07 -27.98 -93.26 206.68 339.49 24.26 101.89 1.28
% of Revenue 32.01 28.32 26.12 20.09 12.05 7.11 4.16 3.48 7.60 9.50 9.77 7.04 4.84 0.32 0.99 4.58 5.90 12.07 11.94
SG&A 1,278 1,287 1,408 1,448 1,365 1,364 1,350 1,265 1,190 1,022 961 953 995 1,047 1,084 1,050 1,012 1,014 992
Change (%) 0.70 9.39 2.80 -5.72 -0.04 -1.03 -6.34 -5.90 -14.13 -5.96 -0.81 4.35 5.31 3.52 -3.13 -3.67 0.26 -2.21
% of Revenue 11.71 10.74 10.55 9.52 8.70 8.68 8.57 8.00 7.31 6.01 5.49 5.31 5.29 5.51 5.73 5.82 5.81 5.91 5.64
R&D 124 101 106 107 102 168 180 184 187 176 178 193 232 253 279 312 324 194 178
Change (%) -17.98 4.32 1.33 -4.86 64.70 6.99 2.41 1.68 -5.70 1.15 8.41 20.07 8.89 10.40 11.63 4.07 -40.12 -8.40
% of Revenue 1.13 0.85 0.79 0.70 0.65 1.07 1.14 1.16 1.15 1.04 1.02 1.08 1.23 1.33 1.48 1.73 1.86 1.13 1.01
OpEx 8,848 10,015 11,406 13,737 15,308 16,165 16,673 16,732 16,440 16,611 16,960 17,876 19,164 20,312 20,132 18,641 17,788 16,358 16,709
Change (%) 13.19 13.88 20.44 11.44 5.60 3.15 0.35 -1.75 1.05 2.10 5.40 7.20 5.99 -0.89 -7.40 -4.58 -8.04 2.15
% of Revenue 81.05 83.55 85.48 90.37 97.54 102.89 105.77 105.88 101.06 97.78 96.98 99.62 101.88 106.76 106.45 103.24 102.19 95.24 95.05
Operating Income 2,069 1,971 1,937 1,463 387 -454 -910 -929 -172 378 528 68 -354 -1,286 -1,220 -585 -381 818 870
Change (%) -4.71 -1.75 -24.45 -73.56 -217.38 100.38 2.14 -81.49 -319.49 39.82 -87.17 -622.41 263.29 -5.13 -52.01 -34.89 -314.63 6.38
% of Revenue 18.95 16.45 14.52 9.63 2.46 -2.89 -5.77 -5.88 -1.06 2.22 3.02 0.38 -1.88 -6.76 -6.45 -3.24 -2.19 4.76 4.95
Interest Expense -191 -196 -198 -197 -220 -206 -212 -284 -232 -249 -254 -200 -260 -246 -221 -211 -184 -179 -172
Change (%) 2.62 0.90 -0.31 11.42 -6.33 2.96 33.63 -18.31 7.30 2.24 -21.39 30.27 -5.65 -9.90 -4.40 -13.12 -2.62 -3.78
% of Revenue -1.75 -1.64 -1.48 -1.30 -1.40 -1.31 -1.35 -1.79 -1.42 -1.46 -1.45 -1.11 -1.38 -1.29 -1.17 -1.17 -1.06 -1.04 -0.98
Net Income 1,820 1,720 1,687 1,128 50 -703 -1,073 -1,042 -252 281 336 -69 -482 -1,363 -1,295 -639 -293 605 699
Change (%) -5.49 -1.95 -33.13 -95.57 -1,506.45 52.73 -2.96 -75.81 -211.43 19.70 -120.54 597.62 183.10 -5.01 -50.63 -54.12 -306.28 15.55
% of Revenue 16.67 14.35 12.64 7.42 0.32 -4.47 -6.81 -6.59 -1.55 1.65 1.92 -0.38 -2.56 -7.17 -6.85 -3.54 -1.69 3.52 3.98

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista